Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.86 is 82% below its 5-year average of -1.02, around the middle of its 5-year range (-4.59–4.07).
46.78% above its 12-month average of -3.50.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.48.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:29:00.340Z. Historical observations retain their original dates. Historical series through 2023-05-08.
EARNINGS PER SHARE (EPS)
-1.86
EARNINGS PER SHARE (EPS) AVG TTM
-3.50
EARNINGS PER SHARE (EPS) AVG 3Y
-1.92
EARNINGS PER SHARE (EPS) AVG 5Y
-1.02
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+46.78%
CURRENT VS 3Y AVG
+3.25%
CURRENT VS 5Y AVG
-82.06%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Vir Biotechnology, Inc.
Market Cap
$1.96B
Earnings Per Share (EPS)
-1.86
TTM Avg
-3.50
3Y Avg
-1.92
5Y Avg
-1.02
Market Cap
$1.95B
Earnings Per Share (EPS)
-0.68
TTM Avg
-0.29
3Y Avg
-0.44
5Y Avg
-0.50
Market Cap
$1.97B
Earnings Per Share (EPS)
4.62
TTM Avg
3.38
3Y Avg
1.11
5Y Avg
0.12
Market Cap
$1.98B
Earnings Per Share (EPS)
-0.93
TTM Avg
-7.24
3Y Avg
-4.12
5Y Avg
-3.06
Market Cap
$1.94B
Earnings Per Share (EPS)
-4.24
TTM Avg
-2.98
3Y Avg
-3.43
5Y Avg
-3.06
Market Cap
$1.92B
Earnings Per Share (EPS)
-1.31
TTM Avg
-2.36
3Y Avg
-2.72
5Y Avg
-2.37
Market Cap
$2.02B
Earnings Per Share (EPS)
2.29
TTM Avg
1.09
3Y Avg
0.22
5Y Avg
-0.23
Market Cap
$2.02B
Earnings Per Share (EPS)
-1.98
TTM Avg
-3.08
3Y Avg
-3.62
5Y Avg
-4.23
Market Cap
$1.89B
Earnings Per Share (EPS)
-7.01
TTM Avg
2.37
3Y Avg
-1.46
5Y Avg
-2.11
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | $1.96B | -1.86 | -3.50 | -1.92 | -1.02 |
| AxoGen, Inc. (AXGN)vs › | $1.95B | -0.68 | -0.29 | -0.44 | -0.50 |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.97B | 4.62 | 3.38 | 1.11 | 0.12 |
| Fortrea Holdings Inc. (FTRE)vs › | $1.98B | -0.93 | -7.24 | -4.12 | -3.06 |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.94B | -4.24 | -2.98 | -3.43 | -3.06 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | -1.31 | -2.36 | -2.72 | -2.37 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 2.29 | 1.09 | 0.22 | -0.23 |
| UroGen Pharma Ltd. (URGN)vs › | $2.02B | -1.98 | -3.08 | -3.62 | -4.23 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | -7.01 | 2.37 | -1.46 | -2.11 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.02B | -1.50 | 0.42 | -0.42 | -0.63 |
Trailing EPS (TTM)
$-1.86
Forward EPS (Est.)
$-1.77
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.16 |
| 2024-12-31 | -3.83 |
| 2023-12-31 | -4.59 |
| 2022-12-31 | 3.89 |
| 2021-12-31 | 4.07 |
| 2020-12-31 | -2.51 |
| 2019-12-31 | -1.62 |
| 2018-12-31 | -1.20 |
| 2017-12-31 | -10.02 |
